Author:
Tanoshima Reo,Inagaki Naoko,Nitta Manabu,Sue Soichiro,Shimizu Sayuri,Haze Tatsuya,Senuki Kotaro,Sano Chihiro,Takase Hajime,Kaneko Makoto,Nozaki Akito,Okada Kozo,Ohyama Kohei,Kawaguchi Atsushi,Kobayashi Yusuke,Oi Hideki,Maeda Shin,Yano Yuichiro,Kumagai Yuji,Miyagi Etsuko
Funder
Japan Agency for Medical Research and Development
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. Nichol AD, Bailey M, Cooper DJ, et al. Challenging issues in randomised controlled trials. Injury. 2010;41(Suppl 1):S20–3.
2. Kostis JB, Dobrzynski JM. Limitations of randomized clinical trials. Am J Cardiol. 2020;129:109–15.
3. Zhu R, Vora B, Menon S, et al. Clinical pharmacology applications of real-world data and real-world evidence in drug development and approval–an industry perspective. Clin Pharmacol Ther. 2023;114(4):751–67.
4. Minichmayr IK, Smith DM, Giacomini KM, et al. Trends in clinical pharmacology and therapeutics. Clin Pharmacol Ther. 2023;114:11–4.
5. European Medicines Agency. ICH E6 (R2) Good clinical practice– Scientific guideline. https://www.ema.europa.eu/en/ich-e6-r2-good-clinical-practice-scientific-guideline#current-version--section